Bromo‐ and extraterminal domain protein inhibition improves immunotherapy efficacy in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Bromo‐ and extraterminal domain protein inhibition improves immunotherapy efficacy in hepatocellular carcinoma

Published:2020-08-17 Issue:10 Volume:111 Page:3503-3515
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Liu Chen¹²,Miao Xiaolong¹²,Wang Yao³,Wen Liang⁴,Cheng Xiawei⁵,Kong Deqiang¹²,Zhao Pengwei⁶,Song Dandan⁶,Wang Xinyi⁶,Ding Xianfeng³,Xia Hongguang⁷,Wang Weilin¹²^ORCID,Sun Qiming⁶,Gong Weihua¹²^ORCID

Affiliation:

1. Department of Surgery Second Affiliated Hospital of School of Medicine Zhejiang University Hangzhou China

2. Cancer Center Zhejiang University Hangzhou China

3. College of Life Sciences and Medicine Zhejiang Sci‐Tech University Hangzhou China

4. Department of Hepatobiliary Surgery First Affiliated Hospital of School of Medicine Zhejiang University Hangzhou China

5. Synthetic Biology and Biotechnology Laboratory State Key Laboratory of Bioreactor Engineering School of Pharmacy East China University of Science and Technology Shanghai China

6. Department of Biochemistry, and Department of Cardiology of Second Affiliated Hospital of School of Medicine Zhejiang University Hangzhou China

7. Department of Biochemistry and Molecular Biology of School of Medicine Zhejiang University Hangzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14588

Reference41 articles.

1. Hepatocellular carcinoma